Announcements Trials
Browse Landscape

Phase

Phase 2 19Phase 3 16Phase NA 7Phase 1 4Phase EARLY_PHASE1 2Phase 2/3 2Phase 1/2 2Phase 4 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2Gastrointestinal 2

Conditions

Stomach Neoplasms 1Peritoneal Neoplasms 1Carcinoma, Ovarian Epithelial 1

Interventions

Paclitaxel 12Carboplatin 11Cisplatin 9Letrozole 6Drug Therapy 6liposomal doxorubicin 5Megestrol Acetate 4Bevacizumab 4spartalizumab 3Topotecan 3Taxes 3Medroxyprogesterone Acetate 3olaparib 2niraparib 2atezolizumab 2Methotrexate 2Magnetic Resonance Spectroscopy 2Imiquimod 2Hyperthermic Intraperitoneal Chemotherapy 2Gonadotropin-Releasing Hormone 2Gemcitabine 2Doxorubicin 21-dodecylpyridoxal 2trametinib 1sintilimab 1saracatinib 1ricin A-GnRH conjugate 1pertuzumab 1pembrolizumab 1pegfilgrastim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Hyperthermic Intraperitoneal Chemotherapy × Gynecologic × Clear all
NCT01091636 2020-02-17

Intraoperative Hyperthermic Intraperitoneal Chemotherapy With Ovarian Cancer

National Cancer Center, Korea

Phase 2/3 Completed
184 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial

NCT01683864 2018-01-30

HIPECStomach

University Hospital Tuebingen

Phase 2/3 Terminated
3 enrolled
GastrointestinalGynecologic

Peritoneal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡